Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Edesa Biotech Inc (EDSA)

Edesa Biotech Inc (EDSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Edesa Biotech Inc 100 SPY COURT MARKHAM A6 L3R 5H6 CAN

www.edesabiotech.com Employees: 16 P: 289-800-9600 F: 805-488-2889

Sector:

Medical

Description:

Edesa Biotech Inc. is a biopharmaceutical company. It is focused on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company's product pipeline consists of EB01, EB02 and EB04 which are in clinical stage. Edesa Biotech Inc., formerly known as Stellar Biotechnologies Inc., is based in TORONTO.

Key Statistics

Overview:

Market Capitalization, $K 12,334
Enterprise Value, $K 11,294
Shares Outstanding, K 8,334
Annual Sales, $ 0 K
Annual Net Income, $ -7,190 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,230 K
EBIT, $ -5,440 K
EBITDA, $ -6,820 K
60-Month Beta 0.08
% of Insider Shareholders 22.60%
% of Institutional Shareholders 5.50%
Float, K 6,450
% Float 77.40%
Short Interest 51
Short Float 0.61%
Short Volume Ratio 0.14

Growth:

1-Year Return -14.68%
3-Year Return -89.98%
5-Year Return -95.59%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 75.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 12/12/25
Next Earnings Date 02/13/26
Earnings Per Share ttm -1.35
EPS Growth vs. Prev Qtr -28.00%
EPS Growth vs. Prev Year -10.34%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 10/11/23

EDSA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -182.59%
Return-on-Assets % -58.70%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.12
Book Value/Share 2.01
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar